We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Real-Time Imaging Methods Captures Cell Movements in Breast Cancer

By LabMedica International staff writers
Posted on 07 Oct 2008
A new innovation in cellular imaging is allowing scientists to better understand the movement of cells in the area around tumors, also known as the tumor microenvironment. More...


In a recent article published in the September/October 2008 issue of the journal Disease Models & Mechanisms (DMM), Dr. Zena Werb, from the University of California, San Francisco (USA), and colleagues from various other institutions used optimized methods of laser microscopy to track the movement of live cells in a mouse model of breast cancer.

As a tumor grows, it triggers immune responses in the body, and recruits help from healthy cells in order to "feed” and support the spread of the cancerous growth. The influence of the tumor on neighboring cells is dependent on the microenvironment surrounding the tumor. Various immune cells and structural proteins defend the body against the tumor, while others help the tumor grow and spread.

To watch the activity of these cells, researchers injected fluorescent dyes near tumors in mouse models of breast cancer, which also expressed fluorescently tagged cells. A specially designed microscope allowed live imaging of tumor-associated cells for more than 12 hours, while retaining the high resolution necessary to visualize individual cells move in real time. The investigators noticed that subsets of immune cells move differently--some migrate along blood vessels, whereas others remain at the border of the tumor. Furthermore, alterations in the tumor microenvironment, such as a reduction of oxygen, caused some immune cells to stop migrating.

This study, according to the investigators, provides clues into how specific immune cells help or inhibit tumor growth. This then helps in identifying drug targets that can be inhibited to prevent the spread of cancer, or conversely, targets that can be stimulated to enhance the body's natural immune response to cancer. Moreover, this new imaging technique has potential beyond studying cancer, such as watching cell movement in other tissues and organs, both diseased and healthy.

Related Links:
University of California, San Francisco



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.